U.S. flag

An official website of the United States government

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Clinical Review Report: Dapagliflozin (Forxiga): (AstraZeneca Canada Inc.): Indication: Heart failure with reduced ejection fraction [Internet]. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2021 Mar.

Cover of Clinical Review Report: Dapagliflozin (Forxiga)

Clinical Review Report: Dapagliflozin (Forxiga): (AstraZeneca Canada Inc.): Indication: Heart failure with reduced ejection fraction [Internet].

Show details

Abbreviations

6MWD

6-minute walk distance

ACEI

angiotensin-converting enzyme inhibitor

ANCOVA

analysis of covariance

ARB

angiotensin receptor blocker

CHFC

Cardiac Health Foundation of Canada

CI

confidence interval

CV

cardiovascular

eGFR

estimated glomerular filtration rate

EQ-5D

EuroQol 5-Dimensions questionnaire

EQ-5D-3L

EuroQol 5-Dimensions 3-Levels questionnaire

EQ-5D-5L

EuroQol 5-Dimensions 5-Levels questionnaire

EQ VAS

EuroQol Visual Analogue Scale

ESRD

end-stage renal disease

HF

heart failure

HFrEF

heart failure with reduced ejection fraction

HFSG

Heart Failure Support Group of Manitoba

HR

hazard ratio

ICC

intraclass correlation coefficient

ITC

indirect treatment comparison

KCCQ

Kansas City Cardiomyopathy Questionnaire

KCCQ-cs

Kansas City Cardiomyopathy Questionnaire clinical summary score

KCCQ-os

Kansas City Cardiomyopathy Questionnaire overall score

LVEF

left ventricular ejection fraction

MAIC

matching-adjusted indirect comparison

MID

minimal important difference

NT-proBNP

N-terminal pro B-type natriuretic peptide

NYHA

New York Heart Association

OR

odds ratio

PY

person-year

RCT

randomized controlled trial

SD

standard deviation

SF-12

Short Form (12) Health Survey

SGLT2

sodium-glucose cotransporter-2

Copyright © 2021 Canadian Agency for Drugs and Technologies in Health.

The copyright and other intellectual property rights in this document are owned by CADTH and its licensors. These rights are protected by the Canadian Copyright Act and other national and international laws and agreements. Users are permitted to make copies of this document for non-commercial purposes only, provided it is not modified when reproduced and appropriate credit is given to CADTH and its licensors.

Except where otherwise noted, this work is distributed under the terms of a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International licence (CC BY-NC-ND), a copy of which is available at http://creativecommons.org/licenses/by-nc-nd/4.0/

Bookshelf ID: NBK572280

Views

  • PubReader
  • Print View
  • Cite this Page
  • PDF version of this title (1.7M)

Other titles in this collection